𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tobramycin Powder for Inhalation for the Treatment of Cystic Fibrosis: Analysis of the RAMQ Data

✍ Scribed by Lachaine, J.; Lapierre, M.E.; Beauchemin, C.; Balp, M.M.; Calado, F.; Debonnett, L.; Desforges, J.; Sagkriotis, A.

Book ID
122105423
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
63 KB
Volume
16
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Systematic review of the dry powder inha
Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis
✍ Uttley, L.; Harnan, S.; Cantrell, A.; Taylor, C.; Walshaw, M.; Brownlee, K.; Tap πŸ“‚ Article πŸ“… 2013 πŸ› European Respiratory Society 🌐 English βš– 427 KB

This systematic review evaluated evidence for two dry powder formulations, colistimethate sodium and tobramycin, for the treatment of chronic __Pseudomonas aeruginosa__ in cystic fibrosis, as part of the UK national recommendation process for new technologies. Electronic bibliographic databases were